查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1296824

欧洲、亚洲、中东和非洲医疗器械市场预测（至 2030 年）

Europe, Asia, Middle East & Africa Medical Devices Market Research Report Forecast to 2030
出版日期: | 出版商: Market Research Future | 英文 360 Pages | 订单完成后即时交付

价格

本报告研究和分析了欧洲、亚洲、中东和非洲的医疗器械市场，提供了有关每个地区的人口统计数据、主要参与者以及 COVID-19 影响的信息。

内容

第一章市场介绍

第 2 章人口统计分析：国家

  • 概述
  • 年龄人口统计数据
  • 国内生产总值 (GDP)
  • 医疗支出（2019-2021 年）
  • 统计分析：疾病发生率、患病率和死亡率
    • 血管内治疗：按疾病分类
    • 心脏病
    • 手术：按疾病分类
  • 消费能力
  • 患者对治疗方案的了解
  • 按地区划分的主要医院列表
    • 罗马尼亚
    • 白俄罗斯
    • 伊朗
    • 伊拉克
    • 塞尔维亚
    • 阿塞拜疆
    • 阿尔及利亚
    • 突尼斯
    • 摩洛哥
    • 埃及
    • 尼日利亚
    • 肯尼亚
    • 乌兹别克斯坦
    • 巴基斯坦
    • 乌克兰
    • 波斯尼亚和黑塞哥维那

第 3 章：市场因素分析范围：按国家/地区

  • 外周动脉疾病：市场分析
  • 腹主动脉瘤 (AAA)/胸主动脉瘤 (TAA)
  • 卵圆孔未闭 (PFO)/房间隔缺损 (ASD)
  • 疝气和减肥手术

第 4 章：各国血管内和心臟市场分析

  • 腹主动脉瘤 (AAA)
  • 欧洲、亚洲、中东和非洲的腹主动脉瘤：国家级分析
  • 胸主动脉瘤 (TAA)
  • 欧洲/亚洲/中东/非洲：胸主动脉瘤 (TAA) 市场：国家层面分析
  • 外周动脉疾病 (PAD) 概述
  • 血管移植市场，概述
  • 欧洲/亚洲/中东/非洲：国家/地区层面分析
  • 卵圆孔未闭 (PFO)
  • 欧洲/亚洲/中东/非洲：卵圆孔未闭 (PFO) 市场：国家/地区分析
  • 房间隔缺损 (ASD)

第 5 章减肥手术：市场分析

  • 概述
  • 袖状胃切除术市场概览
  • Roux-en-Y 胃绕道手术 (RYGB) 概述
  • 支撑设备（钉线加固）

第六章疝气修復手术：市场分析

  • 概述
  • 疝气修復手术市场：按疝气类型划分（2018-2030）
  • 按产品划分的疝气修復手术市场（2018-2030）
  • 生物可吸收网

第 7 章：报销和监管环境分析

  • 赎回情况
  • 监管环境分析：按国家/地区分类

第 8 章竞争格局

  • 欧洲、中东和非洲医疗器械市场市场份额分析（2021-2022 年）
  • 竞争分析：按国家/地区分类
  • 价格分析（2021-2022 年）
  • 财务矩阵分析
  • 按国家/地区划分的市场进入者
  • 主要经销商（按国家/地区划分）
  • 欧洲、亚洲、中东和非洲医疗器械市场的主要发展

第 9 章观察和结论

    • 市场机会分析：按国家/地区分类
    • PAD市场分析
    • AAA市场分析
    • TAA市场分析
    • PFO/ASD 市场分析
    • 肥胖及疝气手术市场分析

第 10 章附录

Market Overview

The countries within the scope of the study have been analyzed basis of a few factors to gather an understanding of the patient population and the countries. A Patent Foramen Ovale (PFO) is a hole in the wall between the left and right atria of every human fetus. This hole is a small flaplike opening between the upper heart chambers that allows blood to bypass the fetal lungs, which cannot work until they are exposed to air. When a newborn enters the world and takes its first breath, the foramen ovale closes, and within a few months, it has sealed completely in about 75% of cases and when in some cases it remains open, it is called a PFO. In most people treatment for PFO is not required. However, if a stroke related to the PFO is diagnosed, closure is recommended as it prevents blood clots from moving to other parts of the body such as the brain and heart, which could cause a stroke. Additionally, an Atrial septal defect (ASD) is a congenital heart defect (hole) in the inter-atrial septum that typically allows blood to go from the left to right chambers. The hole increases the amount of blood that passes through the lungs. ASD is one of the most common congenital cardiac diseases and usually affects women more than men. Hence, the rising female population suffering from ASD is driving the Atrial Septal Defect (ASD) market growth during the forecast period. In addition, the increasing prevalence of congenital heart diseases and increasing government spending on healthcare are driving the growth of the Patent Foramen Ovale (PFO) and Atrial Septal Defect (ASD) market. For instance, according to the Eurostat database, healthcare expenditure was EUR 10,73,000 million or 8.0% of GDP in 2020. Hence, rising healthcare expenditure also increases company activities and government initiatives in developing effective heart defect closure devices for the treatment of congenital heart defects to prevent recurrent ischemic stroke. These factors are anticipated to positively impact the growth of the market. Moreover, the high incidence rate for ischemic stroke is expected to augment the growth of the market over the forecast period. Stroke is one of the leading causes of death in Europe, Asia, the Middle East & Africa. Peripheral artery disease (PAD) has changed over time as the prevalence of associated risk factors and co-morbidities including the increase in insulin-dependent diabetes and the changing dynamic of tobacco use has evolved. For instance, countries such as Pakistan, Uzbekistan, Egypt, Azerbaijan, Iran, and Algeria have registered an increase in the prevalence of diabetes and is anticipated to grow in the coming years. This, in turn, will increase the demand for medical devices associated with the treatment of PAD in these countries.

Regional Analysis

Europe, Asia, Middle East & Africa Medical Devices Market is studied across various countries such as Romania, Belarus, Iran, Iraq, Serbia, Azerbaijan, Algeria, Tunisia, Morocco, Egypt, Nigeria, Kenya, Ukraine, Uzbekistan, Pakistan, and Bosnia and Herzegovina

Major Players

Boston Scientific Corporation, Medtronic Plc, B. Braun Melsungen AG, Baxter International Inc., Johnson & Johnson, Merit Medical Systems, Inc., Abbott Laboratories Inc., Becton, Dickinson and Company, CONMED Corporation, Olympus Corporation, and Koninklijke Philips N.V.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 RESEARCH OBJECTIVE

2 DEMOGRAPHIC ANALYSIS BY COUNTRY

  • 2.1 OVERVIEW
  • 2.2 AGE GROUP DEMOGRAPHICS
    • 2.2.1 ANALYST COMMENT
  • 2.3 GROSS DOMESTIC PRODUCT (GDP)
  • 2.4 HEALTHCARE SPENDING, (BILLION EURO), 2019-2021
  • 2.5 STATISTICAL ANALYSIS: DISEASE WISE INCIDENCE, PREVELANCE, AND MORTALITY
    • 2.5.1 ENDOVASCULAR BY DISEASE
      • 2.5.1.1 ABDOMINAL AORTIC ANEURYSM (AAA)
      • 2.5.1.2 THORACIC AORTIC ANEURYSM (TAA)
      • 2.5.1.3 PERIPHERAL ARTERIAL DISEASE (PAD)
    • 2.5.2 CARDIAC DISEASE
      • 2.5.2.1 PATENT FORAMEN OVALE (PFO)
      • 2.5.2.2 ATRIAL SEPTAL DEFECT (ASD)
    • 2.5.3 SURGERY, BY DISEASE
      • 2.5.3.1 OBESITY
      • 2.5.3.2 HERNIA
  • 2.6 SPENDING CAPACITY
    • 2.6.1 ANALYST COMMENT
  • 2.7 PATIENT KNOWLEDGE ABOUT TREATMENT OPTIONS
    • 2.7.1 ANALYST COMMENT
  • 2.8 LIST OF KEY HOSPITALS, BY REGION
    • 2.8.1 ROMANIA
    • 2.8.2 BELARUS
    • 2.8.3 IRAN
    • 2.8.4 IRAQ
    • 2.8.5 SERBIA
    • 2.8.6 AZERBAIJAN
    • 2.8.7 ALGERIA
    • 2.8.8 TUNISIA
    • 2.8.9 MOROCCO
    • 2.8.10 EGYPT
    • 2.8.11 NIGERIA
    • 2.8.12 KENYA
    • 2.8.13 UZBEKISTAN
    • 2.8.14 PAKISTAN
    • 2.8.15 UKRAINE
    • 2.8.16 BOSNIA AND HERZEGOVINA

3 MARKET FACTOR ANALYSIS COVERAGE, BY COUNTRY

  • 3.1 PERIPHERAL ARTERY DISEASE: MARKET ANALYSIS
    • 3.1.1 MARKET TRENDS AND REVENUE POCKETS
    • 3.1.2 MARKET DRIVERS AND RESTRAINTS, BY COUNTRY
      • 3.1.2.1 ROMANIA
      • 3.1.2.2 BELARUS
      • 3.1.2.3 IRAN
      • 3.1.2.4 IRAQ
      • 3.1.2.5 SERBIA
      • 3.1.2.6 AZERBAIJAN
      • 3.1.2.7 ALGERIA
      • 3.1.2.8 TUNISIA
      • 3.1.2.9 MOROCCO
      • 3.1.2.10 EGYPT
      • 3.1.2.11 NIGERIA
      • 3.1.2.12 KENYA
      • 3.1.2.13 UZBEKISTAN
      • 3.1.2.14 PAKISTAN
      • 3.1.2.15 UKRAINE
      • 3.1.2.16 BOSNIA AND HERZEGOVINA
    • 3.1.3 FUTURE POTENTIAL OPPORTUNITY POCKETS
      • 3.1.3.1 INCREASING GOVERNMENT INITIATIVES
      • 3.1.3.2 RISING ADOPTION OF MINIMALLY INVASIVE PROCEDURES AND COMPANY INITIATIVES
      • 3.1.3.3 INCREASING ADOPTION OF UNHEATHY LIFESTYLE AND FOOD HABITS
    • 3.1.4 IMPACT OF CORONAVIRUS (COVID-19) PANDEMIC ON MARKET
    • 3.1.5 STATISTICAL OVERVIEW: BYPASS PROCEDURES, 2021-2022
    • 3.1.6 LEG AMPUTATION
  • 3.2 ABDOMINAL AORTIC ANEURYSM (AAA) AND THORACIC AORTIC ANEURYSM (TAA)
    • 3.2.1 AAA AND TAA MARKET TRENDS, DRIVERS, AND RESTRAINTS
    • 3.2.2 MARKET DRIVERS AND RESTRAINTS
      • 3.2.2.1 ROMANIA
      • 3.2.2.2 BELARUS
      • 3.2.2.3 IRAN
      • 3.2.2.4 IRAQ
      • 3.2.2.5 SERBIA
      • 3.2.2.6 AZERBAIJAN
      • 3.2.2.7 ALGERIA
      • 3.2.2.8 TUNISIA
      • 3.2.2.9 MOROCCO
      • 3.2.2.10 EGYPT
      • 3.2.2.11 NIGERIA
      • 3.2.2.12 KENYA
      • 3.2.2.13 UZBEKISTAN
      • 3.2.2.14 PAKISTAN
      • 3.2.2.15 UKRAINE
      • 3.2.2.16 BOSNIA AND HERZEGOVINA
    • 3.2.3 AAA AND TAA MARKET OPPORTUNITIES AND REVENUE POCKETS
      • 3.2.3.1 INCREASING GOVERNMENT INITIATIVES
      • 3.2.3.2 INCREASING ADOPTION OF UNHEATHY LIFESTYLE AND FOOD HABITS
      • 3.2.3.3 TECHNOLOGICAL ADVANCEMENTS IN AAA AND TAA TREATMENT
    • 3.2.4 IMPACT OF THE CORONAVIRUS (COVID-19) PANDEMIC ON AAA AND TAA MARKET
  • 3.3 PATENT FORAMEN OVALE (PFO) AND ATRIAL SEPTAL DEFECT (ASD)
    • 3.3.1 MARKET TRENDS, DRIVERS, AND RESTRAINTS
    • 3.3.2 MARKET DRIVERS AND RESTRAINTS
      • 3.3.2.1 ROMANIA
      • 3.3.2.2 BELARUS
      • 3.3.2.3 IRAN
      • 3.3.2.4 IRAQ
      • 3.3.2.5 SERBIA
      • 3.3.2.6 AZERBAIJAN
      • 3.3.2.7 ALGERIA
      • 3.3.2.8 TUNISIA
      • 3.3.2.9 MOROCCO
      • 3.3.2.10 EGYPT
      • 3.3.2.11 NIGERIA
      • 3.3.2.12 KENYA
      • 3.3.2.13 UZBEKISTAN
      • 3.3.2.14 PAKISTAN
      • 3.3.2.15 UKRAINE
      • 3.3.2.16 BOSNIA AND HERZEGOVINA
    • 3.3.3 MARKET OPPORTUNITIES AND REVENUE POCKETS
      • 3.3.3.1 GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES
      • 3.3.3.2 TECHNOLOGICAL ADVANCEMENTS IN THE HEART CLOSURE DEVICE INDUSTRY
      • 3.3.3.3 INCREASING GOVERNMENT INITIATIVES
    • 3.3.4 IMPACT OF THE CORONAVIRUS (COVID-19) PANDEMIC ON MARKET
  • 3.4 HERNIA AND BARIATRIC SURGERY
    • 3.4.1 MARKET TRENDS AND REVENUE POCKETS
    • 3.4.2 MARKET DRIVERS AND RESTRAINTS
      • 3.4.2.1 ROMANIA
      • 3.4.2.2 BELARUS
      • 3.4.2.3 IRAN
      • 3.4.2.4 IRAQ
      • 3.4.2.5 SERBIA
      • 3.4.2.6 AZERBAIJAN
      • 3.4.2.7 ALGERIA
      • 3.4.2.8 TUNISIA
      • 3.4.2.9 MOROCCO
      • 3.4.2.10 EGYPT
      • 3.4.2.11 NIGERIA
      • 3.4.2.12 KENYA
      • 3.4.2.13 UZBEKISTAN
      • 3.4.2.14 PAKISTAN
      • 3.4.2.15 UKRAINE
      • 3.4.2.16 BOSNIA AND HERZEGOVINA
    • 3.4.3 FUTURE POTENTIAL OPPORTUNITY POCKETS
      • 3.4.3.1 INCREASING GOVERNMENT INITIATIVES
      • 3.4.3.2 RISING ADOPTION OF MINIMALLY INVASIVE PROCEDURES
      • 3.4.3.3 INCREASING ADOPTION OF UNHEATHY LIFESTYLE AND FOOD HABITS
      • 3.4.3.4 TECHNOLOGICAL ADVANCEMENTS IN BARIATRIC AND HERNIA SURGERY
      • 3.4.3.5 EXPANSION OF MAJOR GLOBAL PLAYERS INTO THE DEVELOPING COUNTRIES
    • 3.4.4 IMPACT OF THE CORONAVIRUS (COVID-19) PANDEMIC ON MARKET

4 MARKET ANALYSIS FOR ENDOVASCULAR AND CARDIAC DISEASE, BY COUNTRY

  • 4.1 ABDOMINAL AORTIC ANEURYSM (AAA)
    • 4.1.1 REALISTIC SCENARIO
    • 4.1.2 PESSIMISTIC SCENARIO
    • 4.1.3 OPTIMISTIC SCENARIO
  • 4.2 EUROPE, ASIA, AND MIDDLE EAST & AFRICA ABDOMINAL AORTIC ANEURYSM: COUNTRY LEVEL ANALYSIS
    • 4.2.1 ROMANIA
    • 4.2.2 BELARUS
    • 4.2.3 IRAN
    • 4.2.4 IRAQ
    • 4.2.5 SERBIA
    • 4.2.6 AZERBAIJAN
    • 4.2.7 ALGERIA
    • 4.2.8 TUNISIA
    • 4.2.9 MOROCCO
    • 4.2.10 EGYPT
    • 4.2.11 NIGERIA
    • 4.2.12 KENYA
    • 4.2.13 UKRAINE
    • 4.2.14 UZBEKISTAN
    • 4.2.15 PAKISTAN
    • 4.2.16 BOSNIA AND HERZEGOVINA
  • 4.3 THORACIC AORTIC ANEURYSM (TAA)
    • 4.3.1 REALISTIC SCENARIO
    • 4.3.2 PESSIMISTIC SCENARIO
    • 4.3.3 OPPORTUNISTIC SCENARIO
  • 4.4 EUROPE, ASIA, AND MIDDLE EAST & AFRICA: THORACIC AORTIC ANEURYSM (TAA) MARKET: COUNTRY

LEVEL ANALYSIS 142

    • 4.4.1 ROMANIA
    • 4.4.2 BELARUS
    • 4.4.3 IRAN
    • 4.4.4 IRAQ
    • 4.4.5 SERBIA
    • 4.4.6 AZERBAIJAN
    • 4.4.7 ALGERIA
    • 4.4.8 TUNISIA
    • 4.4.9 MOROCCO
    • 4.4.10 EGYPT
    • 4.4.11 NIGERIA
    • 4.4.12 KENYA
    • 4.4.13 UKRAINE
    • 4.4.14 UZBEKISTAN
    • 4.4.15 PAKISTAN
    • 4.4.16 BOSNIA AND HERZEGOVINA
  • 4.5 PERIPHERAL ARTERY DISEASE (PAD) OVERVIEW
    • 4.5.1 REALISTIC SCENARIO
    • 4.5.2 PESSIMISTIC SCENARIO
    • 4.5.3 OPTIMISTIC SCENARIO
  • 4.6 VASCULAR GRAFT MARKET, OVERVIEW
    • 4.6.1 REALISTIC SCENARIO
    • 4.6.2 OPTIMISTIC SCENARIO
    • 4.6.3 PESSIMISTIC SCENARIO
  • 4.7 EUROPE, ASIA, AND MIDDLE EAST & AFRICA: COUNTRY LEVEL ANALYSIS
    • 4.7.1 ROMANIA
    • 4.7.2 BELARUS
    • 4.7.3 IRAN
    • 4.7.4 IRAQ
    • 4.7.5 SERBIA
    • 4.7.6 AZERBAIJAN
    • 4.7.7 ALGERIA
    • 4.7.8 TUNISIA
    • 4.7.9 MOROCCO
    • 4.7.10 EGYPT
    • 4.7.11 NIGERIA
    • 4.7.12 KENYA
    • 4.7.13 UKRAINE
    • 4.7.14 UZBEKISTAN
    • 4.7.15 PAKISTAN
    • 4.7.16 BOSNIA AND HERZEGOVINA
  • 4.8 PATENT FORAMEN OVALE (PFO)
    • 4.8.1 REALISTIC SCENARIO
    • 4.8.2 OPPORTUNISTIC SCENARIO
    • 4.8.3 PESSIMISTIC SCENARIO
  • 4.9 EUROPE, ASIA, AND MIDDLE EAST & AFRICA: PATENT FORAMEN OVALE (PFO) MARKET COUNTRY LEVEL ANALYSIS
    • 4.9.1 ROMANIA
    • 4.9.2 BELARUS
    • 4.9.3 IRAN
    • 4.9.4 IRAQ
    • 4.9.5 SERBIA
    • 4.9.6 AZERBAIJAN
    • 4.9.7 ALGERIA
    • 4.9.8 TUNISIA
    • 4.9.9 MOROCCO
    • 4.9.10 EGYPT
    • 4.9.11 NIGERIA
    • 4.9.12 KENYA
    • 4.9.13 UKRAINE
    • 4.9.14 UZBEKISTAN
    • 4.9.15 PAKISTAN
    • 4.9.16 BOSNIA AND HERZEGOVINA
  • 4.10 ATRIAL SEPTAL DEFECT (ASD)
    • 4.10.1 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER: COUNTRY LEVEL ANALYSIS
      • 4.10.1.1 ROMANIA
      • 4.10.1.2 BELARUS
      • 4.10.1.3 IRAN
      • 4.10.1.4 IRAQ
      • 4.10.1.5 SERBIA
      • 4.10.1.6 AZERBAIJAN
      • 4.10.1.7 ALGERIA
      • 4.10.1.8 TUNISIA
      • 4.10.1.9 MOROCCO
      • 4.10.1.10 EGYPT
      • 4.10.1.11 NIGERIA
      • 4.10.1.12 KENYA
      • 4.10.1.13 UKRAINE
      • 4.10.1.14 UZBEKISTAN
      • 4.10.1.15 PAKISTAN
      • 4.10.1.16 BOSNIA AND HERZEGOVINA

5 BARIATRIC SURGERY: MARKET ANALYSIS

  • 5.1 OVERVIEW
  • 5.2 SLEEVE GASTRECTOMY MARKET OVERVIEW
    • 5.2.1 MARKET SIZE AND FORECAST
      • 5.2.1.1 REALISTIC SCENARIO
    • 5.2.2 SLEEVE GASTRECTOMY MARKET GROWTH MODEL
      • 5.2.2.1 PESSIMISTIC SCENARIO
      • 5.2.2.2 OPPORTUNISTIC SCENARIO
    • 5.2.3 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER: COUNTRY LEVEL ANALYSIS
      • 5.2.3.1 ROMANIA
      • 5.2.3.2 BELARUS
      • 5.2.3.3 IRAN
      • 5.2.3.4 IRAQ
      • 5.2.3.5 SERBIA
      • 5.2.3.6 AZERBAIJAN
      • 5.2.3.7 ALGERIA
      • 5.2.3.8 TUNISIA
      • 5.2.3.9 MOROCCO
      • 5.2.3.10 EGYPT
      • 5.2.3.11 NIGERIA
      • 5.2.3.12 KENYA
      • 5.2.3.13 UZBEKISTAN
      • 5.2.3.14 PAKISTAN
      • 5.2.3.15 UKRAINE
      • 5.2.3.16 BOSNIA AND HERZEGOVINA
  • 5.3 ROUX EN Y GASTRIC BYPASS (RYGB) OVERVIEW
    • 5.3.1 MARKET SIZE AND FORECAST
      • 5.3.1.1 REALISTIC SCENARIO
    • 5.3.2 ROUX EN Y GASTRIC BYPASS (RYGB) GROWTH MODEL
      • 5.3.2.1 PESSIMISTIC SCENARIO
      • 5.3.2.2 OPPORTUNISTIC SCENARIO
    • 5.3.3 EUROPE, ASIA, AND MIDDLE EAST & AFRICA FOR ROUX EN Y GASTRIC BYPASS (RYGB): COUNTRY LEVEL ANALYSIS
      • 5.3.3.1 ROMANIA
      • 5.3.3.2 BELARUS
      • 5.3.3.3 IRAN
      • 5.3.3.4 IRAQ
      • 5.3.3.5 SERBIA
      • 5.3.3.6 AZERBAIJAN
      • 5.3.3.7 ALGERIA
      • 5.3.3.8 TUNISIA
      • 5.3.3.9 MOROCCO
      • 5.3.3.10 EGYPT
      • 5.3.3.11 NIGERIA
      • 5.3.3.12 KENYA
      • 5.3.3.13 UZBEKISTAN
      • 5.3.3.14 PAKISTAN
      • 5.3.3.15 UKRAINE
      • 5.3.3.16 BOSNIA AND HERZEGOVINA
  • 5.4 BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT)
    • 5.4.1 MARKET SIZE AND FORECAST
      • 5.4.1.1 REALISTIC SCENARIO
    • 5.4.2 BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT) GROWTH MODEL
      • 5.4.2.1 PESSIMISTIC SCENARIO
      • 5.4.2.2 OPPORTUNISTIC SCENARIO
    • 5.4.3 EUROPE, ASIA, AND MIDDLE EAST & AFRICA FOR BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT): COUNTRY LEVEL ANALYSIS
      • 5.4.3.1 ROMANIA
      • 5.4.3.2 BELARUS
      • 5.4.3.3 IRAN
      • 5.4.3.4 IRAQ
      • 5.4.3.5 SERBIA
      • 5.4.3.6 AZERBAIJAN
      • 5.4.3.7 ALGERIA
      • 5.4.3.8 TUNISIA
      • 5.4.3.9 MOROCCO
      • 5.4.3.10 EGYPT
      • 5.4.3.11 NIGERIA
      • 5.4.3.12 KENYA
      • 5.4.3.13 UZBEKISTAN
      • 5.4.3.14 PAKISTAN
      • 5.4.3.15 UKRAINE
      • 5.4.3.16 BOSNIA AND HERZEGOVINA

6 HERNIA REPAIR SURGERY: MARKET ANALYSIS

  • 6.1 OVERVIEW
  • 6.2 HERNIA REPAIR SURGERY MARKET, BY HERNIA TYPE, 2018-2030 (USD MILLION)
    • 6.2.1 VENTRAL HERNIA + INCISIONAL HERNIA (BOTH OPEN AND LAPAROSCOPIC SURGERY)
      • 6.2.1.1 REALISTIC SCENARIO
    • 6.2.2 VENTRAL HERNIA + INCISIONAL HERNIA (BOTH OPEN AND LAPAROSCOPIC SURGERY) MARKET GROWTH MODEL
      • 6.2.2.1 PESSIMISTIC SCENARIO
      • 6.2.2.2 OPPORTUNISTIC SCENARIO
    • 6.2.3 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VENTRAL HERNIA + INCISIONAL HERNIA (BOTH OPEN AND LAPAROSCOPIC SURGERY), BY END USER: COUNTRY LEVEL ANALYSIS
      • 6.2.3.1 ROMANIA
      • 6.2.3.2 BELARUS
      • 6.2.3.3 IRAN
      • 6.2.3.4 IRAQ
      • 6.2.3.5 SERBIA
      • 6.2.3.6 AZERBAIJAN
      • 6.2.3.7 ALJERIA
      • 6.2.3.8 TUNISIA
      • 6.2.3.9 MOROCCO
      • 6.2.3.10 EGYPT
      • 6.2.3.11 NIGERIA
      • 6.2.3.12 KENYA
      • 6.2.3.13 UKRAINE
      • 6.2.3.14 UZBEKISTAN
      • 6.2.3.15 PAKISTAN
      • 6.2.3.16 BOSNIA AND HERZEGOVINA
    • 6.2.4 HIATAL HERNIA (LAPAROSCOPIC)
    • 6.2.5 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR HIATAL HERNIA (LAPAROSCOPIC), 2018-2030 (USD MILLION) (REALISTIC)
      • 6.2.5.1 REALISTIC SCENARIO
    • 6.2.6 HIATAL HERNIA (LAPAROSCOPIC) MARKET GROWTH MODEL
      • 6.2.6.1 PESSIMISTIC SCENARIO
      • 6.2.6.2 OPPORTUNISTIC SCENARIO
    • 6.2.7 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR HIATAL HERNIA, BY END USER: COUNTRY LEVEL ANALYSIS
      • 6.2.7.1 ROMANIA
      • 6.2.7.2 BELARUS
      • 6.2.7.3 IRAN
      • 6.2.7.4 IRAQ
      • 6.2.7.5 SERBIA
      • 6.2.7.6 AZERBAIJAN
      • 6.2.7.7 ALGERIA
      • 6.2.7.8 TUNISIA
      • 6.2.7.9 MOROCCO
      • 6.2.7.10 EGYPT
      • 6.2.7.11 NIGERIA
      • 6.2.7.12 KENYA
      • 6.2.7.13 UKRAINE
      • 6.2.7.14 UZBEKISTAN
      • 6.2.7.15 PAKISTAN
      • 6.2.7.16 BOSNIA AND HERZEGOVINA
  • 6.3 HERNIA REPAIR SURGERY MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
    • 6.3.1 PERMANENT SYNTHETIC MESH
      • 6.3.1.1 REALISTIC SCNEARIO
    • 6.3.2 PERMANENT SYNTHETIC MESH MARKET GROWTH MODEL
      • 6.3.2.1 PESSIMISTIC SCENARIO
      • 6.3.2.2 OPPORTUNISTIC SCENARIO
    • 6.3.3 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERMANENT SYNTHETIC MESH, BY END USER: COUNTRY LEVEL ANALYSIS
      • 6.3.3.1 ROMANIA
      • 6.3.3.2 BELARUS
      • 6.3.3.3 IRAN
      • 6.3.3.4 IRAQ
      • 6.3.3.5 SERBIA
      • 6.3.3.6 AZERBAIJAN
      • 6.3.3.7 ALGERIA
      • 6.3.3.8 TUNISIA
      • 6.3.3.9 MOROCCO
      • 6.3.3.10 EGYPT
      • 6.3.3.11 NIGERIA
      • 6.3.3.12 KENYA
      • 6.3.3.13 UKRAINE
      • 6.3.3.14 UZBEKISTAN
      • 6.3.3.15 PAKISTAN
      • 6.3.3.16 BOSNIA AND HERZEGOVINA
    • 6.3.4 INTRAPERITONEAL MESH
      • 6.3.4.1 REALISTIC SCENARIO
    • 6.3.5 INTRAPERITONEAL MESH MARKET GROWTH MODEL
      • 6.3.5.1 PESSIMISTIC SCENARIO
      • 6.3.5.2 OPPORTUNISTIC SCENARIO
    • 6.3.6 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR INTRAPERITONEAL MESH, BY END USER: COUNTRY LEVEL ANALYSIS
      • 6.3.6.1 ROMANIA
      • 6.3.6.2 BELARUS
      • 6.3.6.3 IRAN
      • 6.3.6.4 IRAQ
      • 6.3.6.5 SERBIA
      • 6.3.6.6 AZERBAIJAN
      • 6.3.6.7 ALGERIA
      • 6.3.6.8 TUNISIA
      • 6.3.6.9 MOROCCO
      • 6.3.6.10 EGYPT
      • 6.3.6.11 NIGERIA
      • 6.3.6.12 KENYA
      • 6.3.6.13 UKRAINE
      • 6.3.6.14 UZBEKISTAN
      • 6.3.6.15 PAKISTAN
      • 6.3.6.16 BOSNIA AND HERZEGOVINA
  • 6.4 BIO-ABSORBABLE MESH
    • 6.4.1 REALISTIC SCENARIO
    • 6.4.2 BIO-ABSORBABLE MESH MARKET GROWTH MODEL
      • 6.4.2.1 PESSIMISTIC SCENARIO
      • 6.4.2.2 OPPORTUNISTIC SCENARIO
    • 6.4.3 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BIO-ABSORBABLE MESH, BY END USER: COUNTRY LEVEL ANALYSIS
      • 6.4.3.1 ROMANIA
      • 6.4.3.2 BELARUS
      • 6.4.3.3 IRAN
      • 6.4.3.4 IRAQ
      • 6.4.3.5 SERBIA
      • 6.4.3.6 AZERBAIJAN
      • 6.4.3.7 ALGERIA
      • 6.4.3.8 TUNISIA
      • 6.4.3.9 MOROCCO
      • 6.4.3.10 EGYPT
      • 6.4.3.11 NIGERIA
      • 6.4.3.12 KENYA
      • 6.4.3.13 UKRAINE
      • 6.4.3.14 UZBEKISTAN
      • 6.4.3.15 PAKISTAN
      • 6.4.3.16 BOSNIA AND HERZEGOVINA
    • 6.4.4 BIOLOGIC MESH
      • 6.4.4.1 REALISTIC SCENARIO
    • 6.4.5 BIOLOGIC MESH MARKET GROWTH MODEL
      • 6.4.5.1 PESSIMISTIC SCENARIO
      • 6.4.5.2 OPPORTUNISTIC SCENARIO
    • 6.4.6 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BIOLOGIC MESH, BY END USER: COUNTRY LEVEL ANALYSIS
      • 6.4.6.1 ROMANIA
      • 6.4.6.2 BELARUS
      • 6.4.6.3 IRAN
      • 6.4.6.4 IRAQ
      • 6.4.6.5 SERBIA
      • 6.4.6.6 AZERBAIJAN
      • 6.4.6.7 ALGERIA
      • 6.4.6.8 TUNISIA
      • 6.4.6.9 MOROCCO
      • 6.4.6.10 EGYPT
      • 6.4.6.11 NIGERIA
      • 6.4.6.12 KENYA
      • 6.4.6.13 UKRAINE
      • 6.4.6.14 UZBEKISTAN
      • 6.4.6.15 PAKISTAN
      • 6.4.6.16 BOSNIA AND HERZEGOVINA

7 ANALYSIS OF REIMBURSMENT AND REGULATORY LANDSCAPE

  • 7.1 REIMBURSEMENT LANDSCAPE
    • 7.1.1 GOVERNMENT MEDICARE PROGRAMS
    • 7.1.2 PRIVATE MEDICAL INSURANCE SCENARIO
      • 7.1.2.1 ROMANIA
      • 7.1.2.2 BELARUS
      • 7.1.2.3 IRAN
      • 7.1.2.4 IRAQ
      • 7.1.2.5 SERBIA
      • 7.1.2.6 AZERBAIJAN
      • 7.1.2.7 ALGERIA
      • 7.1.2.8 TUNISIA
      • 7.1.2.9 MOROCCO
      • 7.1.2.10 EGYPT
      • 7.1.2.11 NIGERIA
      • 7.1.2.12 KENYA
      • 7.1.2.13 UZBEKISTAN
      • 7.1.2.14 PAKISTAN
      • 7.1.2.15 BOSNIA AND HERZEGOVINA
    • 7.1.3 DISEASE STATE REIMBURSEMENT
  • 7.2 ANALYSIS OF REGULATORY LANDSCAPE BY COUNTRY
    • 7.2.1 ROMANIA
    • 7.2.2 BELARUS
    • 7.2.3 IRAN
    • 7.2.4 IRAQ
    • 7.2.5 SERBIA
    • 7.2.6 AZERBAIJAN
    • 7.2.7 ALGERIA
    • 7.2.8 TUNISIA
    • 7.2.9 MOROCCO
    • 7.2.10 EGYPT
    • 7.2.11 NIGERIA
    • 7.2.12 KENYA
    • 7.2.13 UZBEKISTAN
    • 7.2.14 PAKISTAN
    • 7.2.15 UKRAINE
    • 7.2.16 BOSNIA AND HERZEGOVINA

8 COMPETITIVE LANDSCAPE

  • 8.1 MARKET SHARE ANALYSIS, EMEA MEDICAL DEVICE MARKET, 2021-2022
    • 8.1.1 CLUSTER 1: EUROPE MARKET SHARE ANALYSIS, 2021-2022 (%)
    • 8.1.2 CLUSTER 2: ASIA MARKET SHARE ANALYSIS, 2021-2022 (%)
    • 8.1.3 CLUSTER 3: MEA MARKET SHARE ANALYSIS, 2021-2022 (%)
  • 8.2 COMPETETIVE INSIGHTS BY COUNTRY
      • 8.2.1.1 ROMANIA
      • 8.2.1.2 BELARUS
      • 8.2.1.3 IRAN
      • 8.2.1.4 IRAQ
      • 8.2.1.5 SERBIA
      • 8.2.1.6 AZERBAIJAN
      • 8.2.1.7 ALGERIA
      • 8.2.1.8 TUNISIA
      • 8.2.1.9 MOROCCO
      • 8.2.1.10 EGYPT
      • 8.2.1.11 NIGERIA
      • 8.2.1.12 KENYA
      • 8.2.1.13 UZBEKISTAN
      • 8.2.1.14 PAKISTAN
      • 8.2.1.15 UKRAINE
      • 8.2.1.16 BOSNIA AND HERZEGOVINA
  • 8.3 PRICING ANALYSIS, 2021-2022
    • 8.3.1 ANEURYSM AND PAD PRODUCT PRICING ANALYSIS, 2021-2022
    • 8.3.2 HERNIA REPAIR PRODUCT PRICING ANALYSIS, 2021-2022
    • 8.3.3 TREATMENT/PROCEDURE: PRICING ANALYSIS, 2021-2022
  • 8.4 FINANCIAL MATRIX ANALYSIS
  • 8.5 MARKET PLAYERS BY COUNTRY
    • 8.5.1 ROMANIA
    • 8.5.2 BELARUS
    • 8.5.3 IRAN
    • 8.5.4 IRAQ
    • 8.5.5 SERBIA
    • 8.5.6 AZERBAIJAN
    • 8.5.7 ALGERIA
    • 8.5.8 TUNISIA
    • 8.5.9 MOROCCO
    • 8.5.10 EGYPT
    • 8.5.11 NIGERIA
    • 8.5.12 KENYA
    • 8.5.13 UZBEKISTAN
    • 8.5.14 PAKISTAN
    • 8.5.15 UKRAINE
    • 8.5.16 BOSNIA AND HERZEGOVINA
  • 8.6 KEY DISTRIBUTORS BY COUNTRY
    • 8.6.1 ROMANIA
    • 8.6.2 BELARUS
    • 8.6.3 IRAN
    • 8.6.4 IRAQ
    • 8.6.5 SERBIA
    • 8.6.6 AZERBAIJAN
    • 8.6.7 ALGERIA
    • 8.6.8 TUNISIA
    • 8.6.9 MOROCCO
    • 8.6.10 EGYPT
    • 8.6.11 NIGERIA
    • 8.6.12 KENYA
    • 8.6.13 UZBEKISTAN
    • 8.6.14 PAKISTAN
    • 8.6.15 UKRAINE
    • 8.6.16 BOSNIA AND HERZEGOVINA
  • 8.7 KEY DEVELOPMENTS IN THE EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET

9 REMARKS AND CONCLUSIONS

    • 9.1.1 COUNTRY WISE MARKET OPPORTUNITY ANALYSIS
    • 9.1.2 PAD MARKET ANALYSIS
    • 9.1.3 AAA MARKET ANALYSIS
    • 9.1.4 TAA MARKET ANALYSIS
    • 9.1.5 PFO AND ASD MARKET ANALYSIS
    • 9.1.6 SURGERY MARKET ANALYSIS

10 APPENDIX

  • 10.1 GLOSSARY
    • 10.1.1 ABDOMINAL AORTIC ANEURYSM (AAA)
      • 10.1.1.1 INFRARENAL AAA
      • 10.1.1.2 PARARENAL AAA
      • 10.1.1.3 ENDOVASCULAR STENT GRAFT
    • 10.1.2 THORACIC AORTIC ANEURYSM (TAA)
    • 10.1.3 PAD
      • 10.1.3.1 PERIPHERAL ARTERY DISEASE (PAD)
      • 10.1.3.1.1 BALLOON CATHETERS 344
      • 10.1.3.1.2 PLAQUE MODIFICATION DEVICES 344
      • 10.1.3.1.3 ANGIOPLASTY STENTS 345
      • 10.1.3.1.4 BARE METAL STENTS 345
      • 10.1.3.1.5 DRUG-ELUTING STENTS 345
      • 10.1.3.1.6 INFERIOR VENA CAVA FILTERS 345
      • 10.1.3.2 BALLOON ANGIOPLASTY
    • 10.1.4 PATENT FORAMEN OVALE (PFO)
    • 10.1.5 ATRIAL SEPTAL DEFECT (ASD)
    • 10.1.6 BARIATRIC AND HERNIA SURGERY
      • 10.1.6.1 BARIATRIC SURGERY
      • 10.1.6.1.1 SLEEVE GASTRECTOMY 345
      • 10.1.6.1.2 ROUX-EN-Y GASTRIC BYPASS (RYGB) 345
      • 10.1.6.1.3 BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT) 346
      • 10.1.6.2 HERNIA REPAIR SURGERY
      • 10.1.6.2.1 VENTRAL HERNIA 346
      • 10.1.6.2.2 HIATAL HERNIA 346
      • 10.1.6.3 HERNIA MESH
      • 10.1.6.3.1 PERMANENT SYNTHETIC MESH 346
      • 10.1.6.3.2 INTRAPERITONEAL MESH 346
  • 10.2 LIST OF ASSUMPTIONS
  • 10.3 RESEARCH METHODOLOGY
    • 10.3.1 PURCHASED DATABASE:
    • 10.3.2 MRFR'S INTERNAL DATABASE
    • 10.3.3 SECONDARY SOURCES:
    • 10.3.4 MAKE THIRD PARTY PERSPECTIVE:
      • 10.3.4.1 PRIMARY RESEARCH
      • 10.3.4.2 INTERVIEW SCOPE:
      • 10.3.4.3 SAMPLE SIZE FOR THE STUDY:
    • 10.3.5 DATA ANALYSIS
      • 10.3.5.1 DATA ANALYSIS MARKET FORMULATION:
    • 10.3.6 RESOURCE ALLOCATION & COST STRUCTURE
  • 10.4 REFERENCES

 

LIST OF TABLES

  • TABLE 1 COUNTRY WISE POPULATION, BY AGE GROUP, 2021 (MILLION) 38
  • TABLE 2 GROSS DP, BY COUNTRY, 2019-2021, (BILLION EURO) 40
  • TABLE 3 PREVALENCE OF DIABETES AMONG POPULATION AGED 29 TO 70 YEARS, BY COUNTRY (THOUSAND), 2021-2022 63
  • TABLE 4 AGE-STANDARDIZED ESTIMATES OF TOBACCO USE PREVALENCE, BY COUNTRY, 2021-2022 (%) 64
  • TABLE 5 AGE-STANDARDIZED ESTIMATES OF TOBACCO SMOKING PREVALENCE, BY COUNTRY, 2021-2022 (%) 65
  • TABLE 6 SMOKING RATES BY COUNTRY, 2021-2022 (%) 67
  • TABLE 7 HEALTHCARE EXPENDITURE, (% OF GDP) 75
  • TABLE 8 STATISTICS OF PAD ASSOCIATED LEG AMPUTATION PROCEDURES (2021-2022) 78
  • TABLE 9 GERIATRIC POPULATION (65 YEARS AND OLDER) TREND, 2018-2021 (% OF TOTAL POPULATION) 79
  • TABLE 10 SMOKING RATES, BY COUNTRY, 2022 (% POPULATION) 88
  • TABLE 11 OBESITY RATES BY COUNTRY, 2023 (% POPULATION) 89
  • TABLE 12 FEMALE POPULATION, BY COUNTRY, 2021 (%) 91
  • TABLE 13 PREVALENCE OF DIABETES AMONG POPULATION AGED 29 TO 70 YEARS, BY COUNTRY (THOUSAND), 2011-2045 103
  • TABLE 14 SMOKING RATES, BY COUNTRY, 2022 (%) 104
  • TABLE 15 OBESITY RATES BY COUNTRY, 2022 104
  • TABLE 16 HEALTHCARE EXPENDITURE, (% OF GDP), 2010 AND 2019 115
  • TABLE 17 MARKET ENTRY ATTRACTIVENESS ANALYSIS, 2021-2022 116
  • TABLE 18 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2030 (USD MILLION) 120
  • TABLE 19 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY PRODUCT, 2018-2030 (USD MILLION) 121
  • TABLE 20 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 121
  • TABLE 21 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 121
  • TABLE 22 ROMANIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY PRODUCT, 2018-2030 (USD MILLION) 122
  • TABLE 23 ROMANIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 122
  • TABLE 24 ROMANIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 122
  • TABLE 25 BELARUS: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 123
  • TABLE 26 BELARUS: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 123
  • TABLE 27 BELARUS MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 123
  • TABLE 28 IRAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 124
  • TABLE 29 IRAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 124
  • TABLE 30 IRAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 124
  • TABLE 31 IRAQ: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 125
  • TABLE 32 IRAQ: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 125
  • TABLE 33 IRAQ: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 125
  • TABLE 34 SERBIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 126
  • TABLE 35 SERBIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 126
  • TABLE 36 SERBIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 126
  • TABLE 37 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 127
  • TABLE 38 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 127
  • TABLE 39 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 127
  • TABLE 40 ALGERIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 128
  • TABLE 41 ALGERIA MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 128
  • TABLE 42 ALGERIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 128
  • TABLE 43 TUNISIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 129
  • TABLE 44 TUNISIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 129
  • TABLE 45 TUNISIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 129
  • TABLE 46 MOROCCO: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 130
  • TABLE 47 MOROCCO: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 130
  • TABLE 48 MOROCCO: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 130
  • TABLE 49 EGYPT: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 131
  • TABLE 50 EGYPT: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 131
  • TABLE 51 EGYPT: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 131
  • TABLE 52 NIGERIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 132
  • TABLE 53 NIGERIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 132
  • TABLE 54 NIGERIA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 132
  • TABLE 55 KENYA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 133
  • TABLE 56 KENYA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 133
  • TABLE 57 KENYA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 133
  • TABLE 58 UKRAINE: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 134
  • TABLE 59 UKRAINE: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 134
  • TABLE 60 UKRAINE: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 134
  • TABLE 61 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 135
  • TABLE 62 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 135
  • TABLE 63 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 135
  • TABLE 64 PAKISTAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 136
  • TABLE 65 PAKISTAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 136
  • TABLE 66 PAKISTAN: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 136
  • TABLE 67 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 137
  • TABLE 68 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY SITE, 2018-2030 (USD MILLION) 137
  • TABLE 69 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, BY END USER, 2018-2030 (USD MILLION) 137
  • TABLE 70 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), 2018-2030 (USD MILLION) 138
  • TABLE 71 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), 2018-2030 (USD MILLION) 138
  • TABLE 72 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), 2018-2030 (USD MILLION) 139
  • TABLE 73 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY COUNTRY, 2018-2030 (USD MILLION) 140
  • TABLE 74 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 140
  • TABLE 75 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 141
  • TABLE 76 ROMANIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 142
  • TABLE 77 ROMANIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 142
  • TABLE 78 BELARUS: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 143
  • TABLE 79 BELARUS: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 143
  • TABLE 80 IRAN: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 144
  • TABLE 81 IRAN: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 144
  • TABLE 82 IRAQ: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 145
  • TABLE 83 IRAQ: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 145
  • TABLE 84 SERBIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 146
  • TABLE 85 SERBIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 146
  • TABLE 86 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 147
  • TABLE 87 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 147
  • TABLE 88 ALGERIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 148
  • TABLE 89 ALGERIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 148
  • TABLE 90 TUNISIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 149
  • TABLE 91 TUNISIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 149
  • TABLE 92 MOROCCO: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 150
  • TABLE 93 MOROCCO: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 150
  • TABLE 94 EGYPT: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 151
  • TABLE 95 EGYPT: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 151
  • TABLE 96 NIGERIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 152
  • TABLE 97 NIGERIA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 152
  • TABLE 98 KENYA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 153
  • TABLE 99 KENYA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 153
  • TABLE 100 UKRAINE: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 154
  • TABLE 101 UKRAINE: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 154
  • TABLE 102 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 155
  • TABLE 103 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 155
  • TABLE 104 PAKISTAN: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 156
  • TABLE 105 PAKISTAN: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 156
  • TABLE 106 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY TREATMENT, 2018-2030 (USD MILLION) 157
  • TABLE 107 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), BY END USER, 2018-2030 (USD MILLION) 157
  • TABLE 108 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 158
  • TABLE 109 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) (PESSIMISTIC) 158
  • TABLE 110 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) (OPPORTUNISTIC) 159
  • TABLE 111 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2018-2030 (USD MILLION) 159
  • TABLE 112 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 160
  • TABLE 113 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 161
  • TABLE 114 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 161
  • TABLE 115 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 162
  • TABLE 116 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) (OPPORTUNISTIC) 162
  • TABLE 117 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) (PESSIMISTIC) 163
  • TABLE 118 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT, BY COUNTRY, 2018-2030 (USD MILLION) 163
  • TABLE 119 ROMANIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 164
  • TABLE 120 ROMANIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 164
  • TABLE 121 ROMANIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 165
  • TABLE 122 ROMANIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 165
  • TABLE 123 ROMANIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 165
  • TABLE 124 ROMANIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 165
  • TABLE 125 BELARUS: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 166
  • TABLE 126 BELARUS: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 166
  • TABLE 127 BELARUS: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 166
  • TABLE 128 BELARUS: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 167
  • TABLE 129 BELARUS: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 167
  • TABLE 130 BELARUS: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 167
  • TABLE 131 IRAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 168
  • TABLE 132 IRAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 168
  • TABLE 133 IRAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 168
  • TABLE 134 IRAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 169
  • TABLE 135 IRAN: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 169
  • TABLE 136 IRAN: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 169
  • TABLE 137 IRAQ: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 169
  • TABLE 138 IRAQ: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 170
  • TABLE 139 IRAQ: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 170
  • TABLE 140 IRAQ: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 170
  • TABLE 141 IRAQ: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 171
  • TABLE 142 IRAQ: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 171
  • TABLE 143 SERBIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 171
  • TABLE 144 SERBIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 171
  • TABLE 145 SERBIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 172
  • TABLE 146 SERBIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 172
  • TABLE 147 SERBIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 172
  • TABLE 148 SERBIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 172
  • TABLE 149 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 173
  • TABLE 150 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 173
  • TABLE 151 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 173
  • TABLE 152 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 174
  • TABLE 153 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 174
  • TABLE 154 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 174
  • TABLE 155 ALGERIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 174
  • TABLE 156 ALGERIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 175
  • TABLE 157 ALGERIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 175
  • TABLE 158 ALGERIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 175
  • TABLE 159 ALGERIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 176
  • TABLE 160 ALGERIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 176
  • TABLE 161 TUNISIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 176
  • TABLE 162 TUNISIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 176
  • TABLE 163 TUNISIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 177
  • TABLE 164 TUNISIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 177
  • TABLE 165 TUNISIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 177
  • TABLE 166 TUNISIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 177
  • TABLE 167 MOROCCO: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 178
  • TABLE 168 MOROCCO: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 178
  • TABLE 169 MOROCCO: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 178
  • TABLE 170 MOROCCO: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 179
  • TABLE 171 MOROCCO: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 179
  • TABLE 172 MOROCCO: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 179
  • TABLE 173 EGYPT: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 179
  • TABLE 174 EGYPT: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 180
  • TABLE 175 EGYPT: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 180
  • TABLE 176 EGYPT: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 180
  • TABLE 177 EGYPT: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 181
  • TABLE 178 EGYPT: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 181
  • TABLE 179 NIGERIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 181
  • TABLE 180 NIGERIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 181
  • TABLE 181 NIGERIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 182
  • TABLE 182 NIGERIA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 182
  • TABLE 183 NIGERIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 182
  • TABLE 184 NIGERIA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 182
  • TABLE 185 KENYA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 183
  • TABLE 186 KENYA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 183
  • TABLE 187 KENYA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 183
  • TABLE 188 KENYA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 184
  • TABLE 189 KENYA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 184
  • TABLE 190 KENYA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 184
  • TABLE 191 UKRAINE: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 184
  • TABLE 192 UKRAINE: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 185
  • TABLE 193 UKRAINE: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 185
  • TABLE 194 UKRAINE: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 185
  • TABLE 195 UKRAINE: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 186
  • TABLE 196 UKRAINE: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 186
  • TABLE 197 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 186
  • TABLE 198 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 186
  • TABLE 199 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 187
  • TABLE 200 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 187
  • TABLE 201 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 187
  • TABLE 202 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 187
  • TABLE 203 PAKISTAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 188
  • TABLE 204 PAKISTAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 188
  • TABLE 205 PAKISTAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 188
  • TABLE 206 PAKISTAN: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 189
  • TABLE 207 PAKISTAN: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 189
  • TABLE 208 PAKISTAN: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 189
  • TABLE 209 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 189
  • TABLE 210 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY PRODUCT, 2018-2030 (USD MILLION) 190
  • TABLE 211 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY ANGIOPLASTY STENTS, 2018-2030 (USD MILLION) 190
  • TABLE 212 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), BY END USER, 2018-2030 (USD MILLION) 190
  • TABLE 213 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, 2018-2030 (USD MILLION) 191
  • TABLE 214 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, BY END USER, 2018-2030 (USD MILLION) 191
  • TABLE 215 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), 2018-2030 (USD MILLION) 191
  • TABLE 216 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), 2018-2030 (USD MILLION) 191
  • TABLE 217 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), 2018-2030 (USD MILLION) 192
  • TABLE 218 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY COUNTRY, 2018-2030 (USD MILLION) 192
  • TABLE 219 ROMANIA: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 193
  • TABLE 220 BELARUS: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 194
  • TABLE 221 IRAN: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 194
  • TABLE 222 IRAQ: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 194
  • TABLE 223 SERBIA: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 195
  • TABLE 224 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 195
  • TABLE 225 ALGERIA: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 195
  • TABLE 226 TUNISIA: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 196
  • TABLE 227 MOROCCO: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 196
  • TABLE 228 EGYPT: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 197
  • TABLE 229 NIGERIA: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 197
  • TABLE 230 KENYA: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 198
  • TABLE 231 UKRAINE: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 198
  • TABLE 232 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 199
  • TABLE 233 PAKISTAN: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 199
  • TABLE 234 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), BY END USER, 2018-2030 (USD MILLION) 200
  • TABLE 235 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY COUNTRY, 2018-2030 (USD MILLION) 201
  • TABLE 236 ROMANIA: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 202
  • TABLE 237 BELARUS: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 202
  • TABLE 238 IRAN: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 203
  • TABLE 239 IRAQ: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 203
  • TABLE 240 SERBIA: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 204
  • TABLE 241 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 204
  • TABLE 242 ALGERIA: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 205
  • TABLE 243 TUNISIA: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 205
  • TABLE 244 MOROCCO: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 206
  • TABLE 245 EGYPT: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 206
  • TABLE 246 NIGERIA: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 207
  • TABLE 247 KENYA: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 207
  • TABLE 248 UKRAINE: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 208
  • TABLE 249 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 208
  • TABLE 250 PAKISTAN: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 209
  • TABLE 251 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER, 2018-2030 (USD MILLION) 209
  • TABLE 252 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BARIATRIC SURGERY, 2018-2030 (USD MILLION) 210
  • TABLE 253 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BARIATRIC SURGERY, BY TYPE, 2018-2030 (USD MILLION) 210
  • TABLE 254 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, 2018-2030 (USD MILLION) (REALISTIC) 211
  • TABLE 255 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, 2018-2030 (USD MILLION) (PESSIMISTIC) 212
  • TABLE 256 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, 2018-2030 (USD MILLION) (OPPORTUNISTIC) 212
  • TABLE 257 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY COUNTRY, 2018-2030 (USD MILLION) 213
  • TABLE 258 NUMBER OF PROCEDURES FOR SLEEVE GASTRECTOMY, BY COUNTRY, 2018-2030 214
  • TABLE 259 ROMANIA: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 214
  • TABLE 260 BELARUS: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 215
  • TABLE 261 IRAN: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 215
  • TABLE 262 IRAQ: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 215
  • TABLE 263 SERBIA: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 216
  • TABLE 264 AZERBAIJAN: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 216
  • TABLE 265 ALGERIA: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 217
  • TABLE 266 TUNISIA: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 217
  • TABLE 267 MOROCCO: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 217
  • TABLE 268 EGYPT: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 218
  • TABLE 269 NIGERIA: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 218
  • TABLE 270 KENYA: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 218
  • TABLE 271 UZBEKISTAN: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 219
  • TABLE 272 PAKISTAN: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 219
  • TABLE 273 UKRAINE: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 219
  • TABLE 274 BOSNIA AND HERZEGOVINA: MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER, 2018-2030 (USD MILLION) 220
  • TABLE 275 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), 2018-2030 (USD MILLION) (REALISTIC) 220
  • TABLE 276 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), 2018-2030 (USD MILLION) (PESSIMISTIC) 221
  • TABLE 277 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), 2018-2030 (USD MILLION) (OPPORTUNISTIC) 221
  • TABLE 278 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), BY COUNTRY, 2018-2030 (USD MILLION) 222
  • TABLE 279 NUMBER OF PROCEDURES FOR ROUX EN Y GASTRIC BYPASS (RYGB), BY COUNTRY, 2018-2030 223
  • TABLE 280 ROMANIA: MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), BY END USER, 2018-2030 (USD MILLION) 223
  • TABLE 281 BELARUS: MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), BY END USER, 2018-2030 (USD MILLION) 224
  • TABLE 282 IRAN: MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), BY

LIST OF FIGURES

  • FIGURE 1 COUNTRY WISE POPULATION, FOR 0-14 AGE GROUP (% TOTAL POPULATION), 2021 39
  • FIGURE 2 COUNTRY WISE POPULATION, FOR 15-64 AGE GROUP (%TOTAL POPULATION), 2021 39
  • FIGURE 3 COUNTRY WISE POPULATION, FOR 65 AND ABOVE AGE GROUP (%TOTAL POPULATION), 2021 40
  • FIGURE 4 ABDOMINAL AORTIC ANEURYSM (AAA), PREVELANCE, 2021 41
  • FIGURE 5 ABDOMINAL AORTIC ANEURYSM (AAA), INCIDENCE, 2021 42
  • FIGURE 6 ABDOMINAL AORTIC ANEURYSM (AAA), FATALITY, 2021 42
  • FIGURE 7 THORACIC AORTIC ANEURYSM (TAA), PREVELANCE, 2021 43
  • FIGURE 8 THORACIC AORTIC ANEURYSM (TAA), INCIDENCE, 2021 43
  • FIGURE 9 THORACIC AORTIC ANEURYSM (TAA), FATALITY, 2021 44
  • FIGURE 10 PERIPHERAL ARTERIAL DISEASE (PAD), PREVELANCE, 2021 44
  • FIGURE 11 PERIPHERAL ARTERIAL DISEASE (PAD), INCIDENCE, 2021 45
  • FIGURE 12 PERIPHERAL ARTERIAL DISEASE (PAD), FATALITY, 2021 45
  • FIGURE 13 PATENT FORAMEN OVALE (PFO), PREVELANCE, 2021 46
  • FIGURE 14 PATENT FORAMEN OVALE (PFO), INCIDENCE, 2021 46
  • FIGURE 15 PATENT FORAMEN OVALE (PFO), FATALITY, 2021 47
  • FIGURE 16 ATRIAL SEPTAL DEFECT (ASD), PREVELANCE, 2021 47
  • FIGURE 17 ATRIAL SEPTAL DEFECT (ASD), INCIDENCE, 2021 48
  • FIGURE 18 ATRIAL SEPTAL DEFECT (ASD), FATALITY, 2021 48
  • FIGURE 19 OBESITY DISEASE PREVELANCE, 2021 49
  • FIGURE 20 OBESITY DISEASE INCIDENCE, 2021 49
  • FIGURE 21 HERNIA DISEASE PREVELANCE, 2021 50
  • FIGURE 22 HERNIA DISEASE MORTALITY, 2021 50
  • FIGURE 23 HEAT MAP ANALYSIS: SPENDING CAPACITY, BY COUNTRY 51
  • FIGURE 24 ANALYSIS OF PATIENT KNOWLEDGE ABOUT TREATMENT OPTIONS 52
  • FIGURE 25 ROMANIA: MARKET FACTOR ANALYSIS, 2021-2022 68
  • FIGURE 26 BELARUS: MARKET FACTOR ANALYSIS, 2021-2022 68
  • FIGURE 27 IRAN: MARKET FACTOR ANALYSIS, 2021-2022 69
  • FIGURE 28 IRAQ: MARKET FACTOR ANALYSIS, 2021-2022 69
  • FIGURE 29 SERBIA: MARKET FACTOR ANALYSIS, 2021-2022 69
  • FIGURE 30 AZERBAIJAN: MARKET FACTOR ANALYSIS, 2021-2022 70
  • FIGURE 31 ALGERIA: MARKET FACTOR ANALYSIS, 2021-2022 70
  • FIGURE 32 TUNISIA: MARKET FACTOR ANALYSIS, 2021-2022 71
  • FIGURE 33 MOROCCO: MARKET FACTOR ANALYSIS, 2021-2022 71
  • FIGURE 34 EGYPT: MARKET FACTOR ANALYSIS, 2021-2022 71
  • FIGURE 35 NIGERIA: MARKET FACTOR ANALYSIS, 2021-2022 72
  • FIGURE 36 KENYA: MARKET FACTOR ANALYSIS, 2021-2022 72
  • FIGURE 37 UZBEKISTAN: MARKET FACTOR ANALYSIS, 2021-2022 72
  • FIGURE 38 PAKISTAN: MARKET FACTOR ANALYSIS, 2021-2022 73
  • FIGURE 39 UKRAINE: MARKET FACTOR ANALYSIS, 2021-2022 73
  • FIGURE 40 BOSNIA AND HERZEGOVINA: MARKET FACTOR ANALYSIS, 2021-2022 73
  • FIGURE 41 BYPASS PROCEDURES BY COUNTRY, 2021 76
  • FIGURE 42 NUMBER OF PAD ASSOCIATED LEG AMPUTATION PROCEDURES (2021-2022) 77
  • FIGURE 43 ROMANIA: MARKET FACTOR ANALYSIS, 2021-2022 80
  • FIGURE 44 BELARUS: MARKET FACTOR ANALYSIS, 2021-2022 80
  • FIGURE 45 IRAN: MARKET FACTOR ANALYSIS, 2021-2022 81
  • FIGURE 46 IRAQ: MARKET FACTOR ANALYSIS, 2021-2022 81
  • FIGURE 47 SERBIA: MARKET FACTOR ANALYSIS, 2021-2022 82
  • FIGURE 48 AZERBAIJAN: MARKET FACTOR ANALYSIS, 2021-2022 82
  • FIGURE 49 ALGERIA: MARKET FACTOR ANALYSIS, 2021-2022 83
  • FIGURE 50 TUNISIA: MARKET FACTOR ANALYSIS, 2021-2022 83
  • FIGURE 51 MOROCCO: MARKET FACTOR ANALYSIS, 2021-2022 84
  • FIGURE 52 EGYPT: MARKET FACTOR ANALYSIS, 2021-2022 84
  • FIGURE 53 NIGERIA: MARKET FACTOR ANALYSIS, 2021-2022 85
  • FIGURE 54 KENYA: MARKET FACTOR ANALYSIS, 2021-2022 85
  • FIGURE 55 UZBEKISTAN: MARKET FACTOR ANALYSIS, 2021-2022 86
  • FIGURE 56 PAKISTAN: MARKET FACTOR ANALYSIS, 2021-2022 86
  • FIGURE 57 UKRAINE: MARKET FACTOR ANALYSIS, 2021-2022 87
  • FIGURE 58 BOSNIA AND HERZEGOVINA: MARKET FACTOR ANALYSIS, 2021-2022 87
  • FIGURE 59 ROMANIA: MARKET FACTOR ANALYSIS, 2021-2022 92
  • FIGURE 60 BELARUS: MARKET FACTOR ANALYSIS, 2021-2022 93
  • FIGURE 61 IRAN: MARKET FACTOR ANALYSIS, 2021-2022 93
  • FIGURE 62 IRAQ: MARKET FACTOR ANALYSIS, 2021-2022 94
  • FIGURE 63 SERBIA: MARKET FACTOR ANALYSIS, 2021-2022 94
  • FIGURE 64 AZERBAIJAN: MARKET FACTOR ANALYSIS, 2021-2022 95
  • FIGURE 65 ALGERIA: MARKET FACTOR ANALYSIS, 2021-2022 95
  • FIGURE 66 TUNISIA: MARKET FACTOR ANALYSIS, 2021-2022 96
  • FIGURE 67 MOROCCO: MARKET FACTOR ANALYSIS, 2021-2022 96
  • FIGURE 68 EGYPT: MARKET FACTOR ANALYSIS, 2021-2022 97
  • FIGURE 69 NIGERIA: MARKET FACTOR ANALYSIS, 2021-2022 97
  • FIGURE 70 KENYA: MARKET FACTOR ANALYSIS, 2021-2022 98
  • FIGURE 71 UZBEKISTAN: MARKET FACTOR ANALYSIS, 2021-2022 98
  • FIGURE 72 PAKISTAN: MARKET FACTOR ANALYSIS 99
  • FIGURE 73 UKRAINE: MARKET FACTOR ANALYSIS 99
  • FIGURE 74 BOSNIA AND HERZEGOVINA: MARKET FACTOR ANALYSIS 100
  • FIGURE 75 ROMANIA: MARKET FACTOR ANALYSIS, 2021-2022 105
  • FIGURE 76 BELARUS: MARKET FACTOR ANALYSIS, 2021-2022 106
  • FIGURE 77 IRAN: MARKET FACTOR ANALYSIS, 2021-2022 106
  • FIGURE 78 IRAQ: MARKET FACTOR ANALYSIS, 2021-2022 107
  • FIGURE 79 SERBIA: MARKET FACTOR ANALYSIS, 2021-2022 107
  • FIGURE 80 AZERBAIJAN: MARKET FACTOR ANALYSIS, 2021-2022 108
  • FIGURE 81 ALGERIA: MARKET FACTOR ANALYSIS, 2021-2022 108
  • FIGURE 82 TUNISIA: MARKET FACTOR ANALYSIS, 2021-2022 109
  • FIGURE 83 MOROCCO: MARKET FACTOR ANALYSIS, 2021-2022 109
  • FIGURE 84 EGYPT: MARKET FACTOR ANALYSIS, 2021-2022 110
  • FIGURE 85 NIGERIA: MARKET FACTOR ANALYSIS, 2021-2022 110
  • FIGURE 86 KENYA: MARKET FACTOR ANALYSIS, 2021-2022 111
  • FIGURE 87 UZBEKISTAN: MARKET FACTOR ANALYSIS, 2021-2022 111
  • FIGURE 88 PAKISTAN: MARKET FACTOR ANALYSIS, 2021-2022 112
  • FIGURE 89 UKRAINE: MARKET FACTOR ANALYSIS, 2021-2022 112
  • FIGURE 90 BOSNIA AND HERZEGOVINA: MARKET FACTOR ANALYSIS, 2021-2022 113
  • FIGURE 91 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, 2018-2030 (USD MILLION) 118
  • FIGURE 92 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ABDOMINAL AORTIC ANEURYSM, COUNTRY, 2018-2030 (USD MILLION) 119
  • FIGURE 93 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), COUNTRY, 2018-2030 (USD MILLION) 139
  • FIGURE 94 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR THORACIC AORTIC ANEURYSM (TAA), COUNTRY, 2018-2030 (USD MILLION) 139
  • FIGURE 95 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), 2018-2030 (USD MILLION) 159
  • FIGURE 96 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERIPHERAL ARTERY DISEASE (PAD), COUNTRY, 2018-2030 (USD MILLION) 160
  • FIGURE 97 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT, COUNTRY, 2018-2030 (USD MILLION) 162
  • FIGURE 98 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VASCULAR GRAFT MARKET, COUNTRY, 2018-2030 (USD MILLION) 164
  • FIGURE 99 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), COUNTRY, 2018-2030 (USD MILLION) 192
  • FIGURE 100 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PATENT FORAMEN OVALE (PFO), COUNTRY, 2018-2030 (USD MILLION) 193
  • FIGURE 101 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), COUNTRY, 2018, 2025 & 2030 (USD MILLION) 200
  • FIGURE 102 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, 2018-2030 (USD MILLION) 211
  • FIGURE 103 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, COUNTRY, 2018-2030 (USD MILLION) 212
  • FIGURE 104 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), 2018-2030 (USD MILLION) 220
  • FIGURE 105 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ROUX EN Y GASTRIC BYPASS (RYGB), COUNTRY, 2018-2030 (USD MILLION) 222
  • FIGURE 106 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT), 2018-2030 (USD MILLION) 229
  • FIGURE 107 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT), COUNTRY, 2018-2030 (USD MILLION) 230
  • FIGURE 108 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VENTRAL HERNIA + INCISIONAL HERNIA (BOTH OPEN AND LAPAROSCOPIC SURGERY), 2018-2030 (USD MILLION) 239
  • FIGURE 109 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VENTRAL HERNIA + INCISIONAL HERNIA (BOTH OPEN AND LAPAROSCOPIC SURGERY), BY COUNTRY, 2018-2030 (USD MILLION) 241
  • FIGURE 110 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, BY HIATAL HERNIA (LAPAROSCOPIC), 2018-2030 (USD MILLION) 249
  • FIGURE 111 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR HIATAL HERNIA (LAPAROSCOPIC), BY COUNTRY, 2018-2030 (USD MILLION) 250
  • FIGURE 112 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERMANENT SYNTHETIC MESH, 2018-2030 (USD MILLION) 258
  • FIGURE 113 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERMANENT SYNTHETIC MESH, BY COUNTRY, 2018-2030 (USD MILLION) 259
  • FIGURE 114 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR INTRAPERITONEAL MESH, 2018-2030 (USD MILLION) 266
  • FIGURE 115 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR INTRAPERITONEAL MESH, BY COUNTRY, 2018-2030 (USD MILLION) 267
  • FIGURE 116 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BIO-ABSORBABLE MESH, 2018-2030 (USD MILLION) 274
  • FIGURE 117 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BIO-ABSORBABLE MESH, BY COUNTRY, 2018-2030 (USD MILLION) 275
  • FIGURE 118 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BIOLOGIC MESH, 2018-2030 (USD MILLION) 282
  • FIGURE 119 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BIO-ABSORBABLE MESH, BY COUNTRY, 2018-2030 (USD MILLION) 283
  • FIGURE 120 ANALYSIS OF DISEASE STATE REIMBURSEMENT 296
  • FIGURE 121 EUROPE MARKET SHARE ANALYSIS FOR DISEASE MARKETS, 2021-2022 311
  • FIGURE 122 EUROPE MARKET SHARE ANALYSIS FOR SURGERY MARKET, 2021-2022 311
  • FIGURE 123 ASIA MARKET SHARE ANALYSIS FOR DISEASE MARKET, 2021-2022 312
  • FIGURE 124 ASIA MARKET SHARE ANALYSIS FOR SURGERY MARKET, 2021-2022 312
  • FIGURE 125 MEA MARKET SHARE ANALYSIS FOR DISEASE MARKETS, 2021-2022 313
  • FIGURE 126 MEA MARKET SHARE ANALYSIS FOR SURGERY MARKET, 2021-2022 313
  • FIGURE 127 ROMANIA: COMPETITIVE INSIGHTS 314
  • FIGURE 128 BELARUS: COMPETETIVE INSIGHTS 314
  • FIGURE 129 IRAN: COMPETETIVE INSIGHTS 315
  • FIGURE 130 IRAQ: COMPETETIVE INSIGHTS 315
  • FIGURE 131 SERBIA: COMPETETIVE INSIGHTS 316
  • FIGURE 132 AZERBAIJAN: COMPETETIVE INSIGHTS 316
  • FIGURE 133 ALGERIA: COMPETETIVE INSIGHTS 317
  • FIGURE 134 TUNISIA: COMPETETIVE INSIGHTS 317
  • FIGURE 135 MOROCCO: COMPETETIVE INSIGHTS 318
  • FIGURE 136 EGYPT: COMPETETIVE INSIGHTS 318
  • FIGURE 137 NIGERIA: COMPETETIVE INSIGHTS 319
  • FIGURE 138 KENYA: COMPETETIVE INSIGHTS 319
  • FIGURE 139 UZBEKISTAN: COMPETETIVE INSIGHTS 320
  • FIGURE 140 PAKISTAN: COMPETETIVE INSIGHTS 320
  • FIGURE 141 UKRAINE: COMPETETIVE INSIGHTS 321
  • FIGURE 142 BOSNIA AND HERZEGOVINA: COMPETETIVE INSIGHTS 321
  • FIGURE 143 MARKET OPPORTUNITY/ATTRACTIVE ANALYSIS, BY COUNTRY 338
  • FIGURE 144 PRIMARY RESEARCH PATTERN 348
  • FIGURE 145 MARKET RESEARCH APPROACHES 351
  • FIGURE 146 VALUE CHAIN BASED SIZING & FORECASTING 354
  • FIGURE 147 RESOURCE ALLOCATION 356